Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTandem Group Regulatory News (TND)

Share Price Information for Tandem Group (TND)

Share Price is delayed by 15 minutes
Get Live Data
173.50    1.00 (0.58%)
Bid:
170.00
Ask:
177.00
Spread: 7.00 (4.118%)
Market Cap: £9.57m
TND Live PriceLast checked at - London Stock Exchange

Intraday Tandem Group Share Chart

Exercise of Options

1 Jun 2011 10:51

RNS Number : 6548H
Tandem Group PLC
01 June 2011
 



 

Tandem Group plc

(the "Company")

 

Exercise of options

 

The Company was informed today that Mervyn Keene, a Director of the Company, has exercised 16,000 options under the 1996 Approved Share Option Scheme, at an exercise price of 62.50 pence per ordinary share of 25 pence each ("Ordinary Share") in the Company. The exercise of options will be satisfied by Ordinary Shares held by the Company in treasury.

Following the exercise of these options, Mervyn Keene is beneficially interested in 216,360 Ordinary Shares, representing 4.6 per cent of the Ordinary Shares in issue. In addition, Mr Keene has the following options over Ordinary Shares:

Director

Option Scheme

Number of options

Option exercise price

Expiry date

Mervyn Keene

1996 Approved Share Option Scheme

15,200

 

71.88p

 

1 May 2013

 

2007 Employee Share Option Scheme

86,400

78.91p

14 June 2020

 

Following the exercise of these options, the Company has 4,666,500 Ordinary Shares in issue and 1,346,980 Ordinary Shares in treasury.

 

 

Enquiries:

Tandem Group plc

Jim Shears

Group Finance Director and Company Secretary

Telephone 0121 748 8075

 

Nominated Adviser

Cairn Financial Advisers LLP

Tony Rawlinson

Telephone 020 7148 7901

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSSSUFFFSEIM
Date   Source Headline
9th Oct 20207:00 amRNSDirectorate Change
30th Sep 20203:09 pmRNSHolding(s) in Company
22nd Sep 20207:00 amRNSHalf-year Report
21st Sep 20207:00 amRNSProposed Director Appointment
28th Aug 20207:00 amRNSTrading Update and Investor Meeting
10th Aug 20204:38 pmRNSHolding(s) in Company
6th Aug 202010:43 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSDirectorate Change
25th Jun 20201:09 pmRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
10th Jun 20209:45 amRNSShareholder Statement
28th May 20207:00 amRNSTrading Update and AGM arrangements
12th May 20203:46 pmRNSHolding(s) in Company
26th Mar 20207:00 amRNSFinal Results
18th Mar 20202:39 pmRNSHolding(s) in Company
28th Feb 202012:45 pmRNSTotal Voting Rights
10th Feb 20207:00 amRNSTrading Update and Board Changes
13th Jan 202011:44 amRNSHolding(s) in Company
13th Jan 202011:42 amRNSHolding(s) in Company
10th Jan 20203:34 pmRNSHolding(s) in Company
10th Jan 202011:19 amRNSHolding(s) in Company
24th Dec 20197:00 amRNSHolding(s) in Company
30th Sep 20197:01 amRNSHalf Yearly Report
30th Sep 20197:00 amRNSBoard Change
5th Aug 20197:00 amRNSHolding(s) in Company
27th Jun 20194:15 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
13th Jun 201910:06 amRNSHolding(s) in Company
3rd Jun 20193:42 pmRNSHolding(s) in Company
24th May 20191:56 pmRNSGrant of Share Options
10th Apr 20197:00 amRNSFinal Results
4th Mar 20197:00 amRNSTrading Statement
28th Sep 20187:00 amRNSHalf-year Report
28th Jun 20183:17 pmRNSResult of AGM
28th Jun 20187:00 amRNSAGM Statement
16th Apr 20187:25 amRNSHolding(s) in Company
11th Apr 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSTrading Statement
29th Sep 20177:00 amRNSHalf-year Report
23rd Jun 20177:13 amRNSResult of AGM
22nd Jun 20177:00 amRNSAGM Statement
20th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSExercise of Options and Directors' Shareholdings
12th Apr 20177:00 amRNSFinal Results
7th Mar 20177:00 amRNSTrading Statement
30th Sep 20167:00 amRNSHalf-year Report
31st Aug 20163:55 pmRNSHolding(s) in Company
28th Jun 20164:22 pmRNSResult of AGM
28th Jun 20167:00 amRNSAGM Statement
14th Jun 20162:12 pmRNSExercise of share options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.